Holdings of NEXTBio Capital Management LP
21 declared positions · as of Mar 31, 2026
Original filing · Ten largest lines: 77 % of the equity sleeve
Sector breakdown
- Unattributed 100.0 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 100.0 %
The quoted currency of each line, as declared.
Country breakdown
- US 88.6 %
- GB 5.8 %
- FR 3.8 %
- KY 1.8 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | US | 18 | 171.9M $ | 88.64 % |
| 2 | GB | 1 | 11.2M $ | 5.77 % |
| 3 | FR | 1 | 7.4M $ | 3.82 % |
| 4 | KY | 1 | 3.4M $ | 1.78 % |
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Terns Pharmaceuticals Inc | 604,534 | 31.9M $ | |
| 2 | Protagonist Therapeutics Inc | 229,619 | 24.2M $ | |
| 3 | Shattuck Labs Inc | 3,149,907 | 20.3M $ | |
| 4 | Vor BioPharma Inc | 999,967 | 17.8M $ | |
| 5 | Compass Pathways plc | 2,021,407 | 11.2M $ | |
| 6 | Rhythm Pharmaceuticals Inc | 126,078 | 11M $ | |
| 7 | Palvella Therapeutics Inc | 82,686 | 10.3M $ | |
| 8 | ZENAS BIOPHARMA INC | 426,736 | 8.3M $ | |
| 9 | Inventiva SACA | 1,333,484 | 7.4M $ | |
| 10 | Verastem Inc | 1,306,800 | 6.9M $ | |
| 11 | ORIC Pharmaceuticals Inc | 523,619 | 6.6M $ | |
| 12 | Structure Therapeutics Inc | 133,239 | 6.4M $ | |
| 13 | Vaxcyte Inc | 95,223 | 5.5M $ | |
| 14 | Cogent Biosciences Inc | 131,188 | 5M $ | |
| 15 | Compass Therapeutics Inc | 848,204 | 4.5M $ | |
| 16 | Evommune Inc | 184,063 | 4.2M $ | |
| 17 | ZAI LAB LTD | 183,362 | 3.4M $ | |
| 18 | Disc Medicine Inc | 52,655 | 3.4M $ | |
| 19 | KalVista Pharmaceuticals Inc | 131,796 | 2.7M $ | |
| 20 | Summit Therapeutics Inc | 89,717 | 1.7M $ | |
| 21 | Adicet Bio Inc | 157,827 | 1.1M $ |